TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Sales | ₹87 Cr | ₹45 Cr | ₹32 Cr | ₹22 Cr |
What is the latest Revenue of TRIDENT LIFELINE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹22 Cr |
How is Revenue of TRIDENT LIFELINE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 94.86 | |
| Mar2024 | ₹45 Cr | 40.82 | |
| Mar2023 | ₹32 Cr | 45.59 | |
| Mar2022 | ₹22 Cr | - | |
Compare Revenue of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹314.3 Cr | -0.4% | 7.1% | -9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -0.4% |
7.1% |
-9.4% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses